5-Chloro-3-(2-methylimidazol-1-ylmethyl)-pyridazine → HCID 22240304, compound
Reaction equation
CC1(C)C(C)(C)OB([C:9]2[CH:18]=[C:17]([CH3:19])[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[CH:10]=2)O1.[Cl:21][C:22]1[CH:23]=[C:24]([CH2:28][N:29]2[CH:33]=[CH:32][N:31]=[C:30]2[CH3:34])[N:25]=[N:26][CH:27]=1>>[ClH:21].[CH3:34][C:30]1[N:29]([CH2:28][C:24]2[N:25]=[N:26][CH:27]=[C:22]([C:9]3[CH:18]=[C:17]([CH3:19])[C:16]4[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=4)[CH:10]=3)[CH:23]=2)[CH:33]=[CH:32][N:31]=1Participants
3
Procedure
The title compound, MS: m/e=351.8 (M+H+), was prepared from 4,4,5,5-tetramethyl-2-(4-methyl-naphthalen-2-yl)-[1,3,2]dioxaborolane and 5-chloro-3-(2-methyl-imidazol-1-yl-methyl)-pyridazine.
Sources & evidence
- ORD record
- ord-544678af4a164441b83fe8f4cac5bd8f
- Source dataset
- uspto-grants-2006_02
- Patent number
- US07005432B2
Reaction notes
Loading…